July 31 (Reuters) - Crescent Biopharma Inc CBIO.O:
CRESCENT BIOPHARMA REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
CRESCENT BIOPHARMA INC: Q2 EPS $-4.93
Source text: ID:nGNX8f4tCn
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))